TY  - BOOK
AU  - Barbash, Israel M
AU  - Ben-Dor, Itsik
AU  - Dvir, Danny
AU  - Lindsay, Joseph
AU  - Maluenda, Gabriel
AU  - Okubagzi, Petros
AU  - Pichard, Augusto D
AU  - Satler, Lowell F
AU  - Torguson, Rebecca
AU  - Waksman, Ron
TI  - Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement
SN  - 1522-1946
PY  - 2013///
KW  - *Aortic Valve Stenosis/th [Therapy]
KW  - *Balloon Valvuloplasty
KW  - *Cardiac Catheterization
KW  - *Heart Valve Prosthesis Implantation/mt [Methods]
KW  - Aged
KW  - Aged, 80 and over
KW  - Aortic Valve Stenosis/di [Diagnosis]
KW  - Aortic Valve Stenosis/mo [Mortality]
KW  - Aortic Valve Stenosis/pp [Physiopathology]
KW  - Aortic Valve Stenosis/su [Surgery]
KW  - Balloon Valvuloplasty/ae [Adverse Effects]
KW  - Balloon Valvuloplasty/mo [Mortality]
KW  - Cardiac Catheterization/ct [Contraindications]
KW  - Female
KW  - Heart Valve Prosthesis Implantation/ct [Contraindications]
KW  - Hemodynamics
KW  - Humans
KW  - Male
KW  - Patient Selection
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Severity of Illness Index
KW  - Time Factors
KW  - Treatment Outcome
KW  - MedStar Heart & Vascular Institute
KW  - Comparative Study
KW  - Journal Article
N1  - Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006
N2  - BACKGROUND: The introduction of transcatheter aortic valve replacement (TAVR) has led to a revival in BAV as treatment for patients with severe aortic stenosis; CONCLUSION: In high-risk patients with aortic stenosis and temporary contraindications to SAVR/TAVR, BAV may be used as a bridge to intervention with good mid-term outcomes. Copyright  2012 Wiley Periodicals, Inc; METHODS: A cohort of 472 patients underwent 538 BAV procedures. The cohort was divided into two groups: BAV alone 387 (81.9%) and BAV as a bridge 85 (18.1%) to (n = 65, TAVR; n = 20, surgery). Clinical, hemodynamic, and follow-up mortality data were collected; OBJECTIVES: This study aimed to determine success- and complication rates after balloon aortic valvuloplasty (BAV) and the outcome of BAV as a standalone therapy versus BAV as a bridge to transcatheter/surgical aortic valve replacement (T/SAVR); RESULTS: There was no significant difference between the two groups in mean age (81.7 + 8.3 vs. 83.2 + 10.9 years, P = 0.18), society of thoracic surgeons score (13.1 + 6.2 and 12.4 + 6.4, P = 0.4), logistic EuroSCORE (45.4 + 22.3 vs. 46.9 + 21.8, P = 0.43), and other comorbidities. The mean increase in aortic valve area was 0.39 + 0.25 in the BAV alone group and 0.42 + 0.26 in the BAV as a bridge group, P = 0.33. The decrease in mean gradient was 24.1 + 13.1 in the BAV alone group vs. 27.1 + 13.8 in the BAV as a bridge group, P = 0.06. During a median follow up of 183 days [54-409], the mortality rate was 55.2% (n = 214) in the BAV alone group vs. 22.3% (n = 19) in the BAV as a bridge group during a median follow-up of 378 days [177-690], P < 0.001
UR  - http://dx.doi.org/10.1002/ccd.24682
ER  -